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Introduction {#sec001}
============

Physiology and behavior of women change extensively throughout pregnancy and around the time of parturition. Relative to other physiological states in women's lives, the day-to-day stability of rest-activity rhythms during late gestation and the early postnatal period is poor and diminishes throughout pregnancy into the early postpartum period \[[@pone.0229567.ref001], [@pone.0229567.ref002]\]. Rest-activity patterns are connected with circadian structure. In non-pregnant women irregular rest-activity patterns associated with shift work, psychological stress and irregular sleep patterns reflect circadian disruption and affect both physiological and neurobehavioral health \[[@pone.0229567.ref003]\]. Although we know that metabolic, circadian, and reproductive systems are integrated and reciprocally regulated \[[@pone.0229567.ref004]--[@pone.0229567.ref007]\], very little is known regarding patterns of rest-activity during gestation and their relationship to hormonal and metabolic adaptations to pregnancy.

Understanding the relationship of rest-activity rhythms with hormones and metabolism is important as growing evidence suggest that circadian disruption associated with irregular rest-activity patterns during pregnancy negatively impacts maternal and fetal health. Retrospective analysis of factory workers found lighter birth weight babies significantly associated with maternal night-shift work \[[@pone.0229567.ref008]\]. Moreover, a population-based prospective study identified maternal sleep deprivation (≤ 8h) and shift work as risk factors for small for gestational age infants \[[@pone.0229567.ref009]\]. Working consecutive night shifts and quick returns after night shifts during the third trimester was found associated with an increased risk of hypertension, particularly among obese women \[[@pone.0229567.ref010]\]. Furthermore, meta-analysis found shiftwork increased relative risk of preterm delivery, low birthweight, and small-for-gestational-age infants \[[@pone.0229567.ref011]\].

The circadian rhythm of circulating cortisol is a primary output of the central clock and functions to synchronize the timing of physiological processes across the body \[[@pone.0229567.ref012], [@pone.0229567.ref013]\]. Circadian rhythms of saliva cortisol, which reflects free-bioavailable cortisol, are maintained throughout pregnancy, despite a progressive decline in the cortisol awakening response and maternal stress reactivity \[[@pone.0229567.ref014], [@pone.0229567.ref015]\]. Studies on the relationship between cortisol circadian rhythms and maternal health outcomes are limited, but indicate that they may be related. For example, studies of waking and evening salivary cortisol in early pregnancy (median gestational week 14) and late pregnancy (median gestational week 30) found women who experienced a stressful life event or were concerned about pregnancy complications during the second trimester had 27% higher evening cortisol. Morning cortisol levels were unaffected \[[@pone.0229567.ref014]\]. Shorter gestation length was associated with higher salivary cortisol concentrations at awakening and throughout the day; with women delivering at 36 weeks gestations having 13% higher cortisol levels at awakening than women delivering at 41 weeks gestation \[[@pone.0229567.ref016]\]. Women with prepregnancy obesity had higher evening cortisol at 35 weeks of gestation compared to women who were not obese prior to pregnancy, however there was no significant association among prepregnancy obesity and cortisol at 24 weeks \[[@pone.0229567.ref017]\].

We hypothesized that irregular rest-activity patterns during pregnancy and the peripartum alter cortisol circadian rhythms and potentially affect maternal-fetal health. Our first step to testing this hypothesis was to conduct a pilot study to determine if 24 h rest-activity and salivary cortisol rhythms in pregnant and early postnatal women were related during gestational weeks 22 and 32 and the first week postpartum. Secondly, we analyzed whether there was a relationship between rest-activity rhythms and cortisol rhythms with maternal-fetal health indicators including prepregnancy BMI, development of gestational related disease, blood glucose levels, gestational age of infant at birth, mood and sleep symptoms as well as actigraphic sleep measures in a population of economically disadvantaged women.

Methods and materials {#sec002}
=====================

Population and setting {#sec003}
----------------------

A longitudinal observational prospective cohort study was approved by Institutional Review Boards (IRB) at Purdue University, Indiana University, and Eskenazi Health (\#1405014855) and was conducted from August 2014 to October 2015. All the women recruited were primiparous, 18--40 years of age, expecting a singleton infant, less than 22 weeks gestational age, and willing to feed baby breast milk. A convenience sample of 92 women was enrolled, and 50 women completed gestational week 22, 46 completed gestational week 32, and 42 women completed all aspects of the study. Loss of fetus, moving or other life events were reasons for half of study withdrawals. The remaining were withdrawn by research staff due to lack of compliance to study protocol. There was no difference in demographic variables between recruited, retained and withdrawn populations \[[@pone.0229567.ref018], [@pone.0229567.ref019]\].

Data collected and study time line ([S1 Fig](#pone.0229567.s001){ref-type="supplementary-material"}) {#sec004}
----------------------------------------------------------------------------------------------------

### Initial data collection {#sec005}

During the initial contact with the participants, a survey was used to gather demographic data, following written and verbal consent. In addition to study consent, participants provided written consent to abstract protected health information (PHI) from the individual's medical records and the medical records of her infant. PHI data collected included pre-pregnancy body mass index (BMI) information, blood glucose levels after 50 g glucose challenge test, and diagnosis of hypertension, preeclampsia and gestational diabetes mellitus (GDM) during pregnancy. The 50 g glucose challenge test was performed between 24--28 weeks pregnancy according to The American Congress of Obstetrics and Gynecologists (ACOG) guidelines. Also abstracted from charts was gestational age of infant at time of birth and infant birth weight.

### Actigraphic data collection {#sec006}

Participants were asked to wear a wrist actigraph device (Actiwatch Spectrum, Philips Respironics, Andover, MA) on their non-dominant wrist and keep a sleep diary for seven consecutive days during gestational weeks 22 and 32 and postpartum week 1 (days 7--14 after birth of infant). Prior to gestational week 22 and 32 a research assistant contacted study participants to schedule time of pick-up actiwatch; at time of pick up instructions on how to wear device and enter sleep log data were given; a time was also arranged for drop-off of device at study site at completion of data collection period. Transportation costs and logistics were covered by the study. Participants were given the actiwatch device at time of hospital discharge; watches were programmed to begin recording beginning at 7 days postpartum. Actigraphic data were collected in 30-sec epochs and Actiware software (Version 5.04; Respironics, Inc.) was used to export activity counts into excel files (<https://purr.purdue.edu/publications/3376>) for calculation of the autocorrelation coefficient at 24 hr (*r*24) and cosinor analysis. Actigraphic sleep variables: (1) sleep onset time, (2) end sleep time, (3) total sleep time, (4) sleep efficiency, (5) time in minutes of wakefulness after sleep onset during the night (WASO) and fragmentation index (FragI) were calculated as previously described \[[@pone.0229567.ref018]\].

### Saliva collection {#sec007}

A subset of women was recruited (n = 38) to measure circadian profiles of saliva cortisol levels at gestation week 22 and 32 and postpartum 24--48 hr. When we reached our targeted number of women (n = 25) for returning samples, this arm of the study was closed. Participants were given saliva sampling kits and instructions on how to sample when they came to pick up the actiwatch for collection of samples at home during gestational week 22 and 32 study periods. For postpartum 24--48 hr period, a research assistant visited each participant in the hospital to give instructions and collect and store vials. For home collections during pregnancy, participants were asked to begin sampling after the 7 days of actiwatch data collection was completed, and to start sampling from the time of waking up. Participants collected saliva samples every four hours for a 24-hour period (from time of waking to the next awakening), for a total of seven samples. Approximately 24 hours after participants delivered their infant, they were asked again to collect saliva samples every 4 hr beginning from 24 hr to 48 hr after delivery. This regimen was selected to standardize sampling times relative to birth since levels of circulating cortisol are expected to change dynamically around the time of parturition. Written instructions given to participants included requests not to drink or eat for at least 60 minutes before the saliva collection, and to maintain their regular sleep habits, despite waking up to collect saliva samples. Subjects were asked to store samples in their home freezer until they transported them to the study site on an ice pack provided in the kit.

*Salivary cortisol analysis*. Salivary cortisol levels were analyzed using commercial enzyme immunoassay kits (Salimetrics, PA). The inter-assay coefficient of variation (CV) was 10%, and the intra-assay coefficient of variation (CV) was 3%. All samples were run in duplicate and the mean value of the duplicate results used.

*Data and statistical analysis*. Robustness of rest-activity circadian rhythms can be assessed by fitting actigraphy data to a cosine curve using the cosinor method, which calculates the relative fit (*R*^2^) as well as mesor (rhythm-adjusted mean), amplitude, and acrophase of the rhythms. The 24-hour autocorrelation coefficient (*r*24) is also a measure of circadian rhythmicity and is calculated by comparing activity data collected during each epoch (a defined period of time, for example 30 sec or 1 min) of a 24-hour period with the activity levels during subsequent 24-hour periods \[[@pone.0229567.ref020]\]. A strong circadian rhythm is indicated by a good correlation between activity levels during epochs separated by 24 hours. Thus, *r*24 estimates the strength of the circadian periodicity, and in theory ranges between -1 and 1 \[[@pone.0229567.ref021]\].

Cosinor analysis of actigraphic activity recordings and cortisol levels was performed using the *Cosinor* package in R 3.2, with the assumption that the period is known and is synchronized to 24-hour cycle. The corresponding mesor, amplitude and acrophase were calculated. The AUC was also calculated for cortisol levels for each subject during each sampling period.

The regression model for a single cosinor can then be written as $$Y\left( t \right) = M + Acos\left( {2\pi t/\tau + \phi} \right) + e\left( t \right)$$ where M is mesor (Midline Statistic of Rhythm, a rhythm adjusted mean), A is amplitude (a measure of distance from the midline to the top of the crest or bottom of trough), ϕ is the acrophase (a measure of time to where the peak happens), τ is the period of one cycle, which is set as 24 hours in our study. And the e(t) is the error term which is assumed to be independent and normally distributed.

By assuming β = Acos(ϕ),γ = −Asin(ϕ),x = cos(2πt/τ) and *z* = sin(2*πt/τ*), Formula ([1](#pone.0229567.e001){ref-type="disp-formula"}) can be easily be rewritten as a linear regression model $$Y\left( t \right) = M + \beta x + \gamma z + e\left( t \right)$$ Which can be easily calculated by any statistical package. After estimating the parameters in (2), the amplitude and acrophase in (1) can be calculated by $$\hat{A} = \sqrt{{\hat{\beta}}^{2} + {\hat{\gamma}}^{2}}$$ $$\hat{\phi} = acrtan\left( - \hat{\gamma}/\hat{\beta} \right) + K\pi$$ Here K is an integer. The correct value of $\hat{\phi}$ is determined by taking both the sign of $\hat{\gamma}$ and $\hat{\beta}$ into consideration.

All participant data collected were entered and stored on a secured server (RedCap). Statistical analysis was conducted using R; *p*-value≤0.05 was considered significant; a *p*-value \>0.05, but \<0.1, was discussed as a tendency, or weak relationship. Repeated measures analysis of variance (ANOVA) was used to determine effect of gestational or postpartum time point on autocorrelation coefficient, followed by Bonferoni adjustments for multiple comparisons. Wilcoxon signed-rank test was used to compare activity and cortisol cosinor analysis variables across the three study timepoints. Because of the limited sample size we were not able to determine the relationship of variables in groups of participants with and without diagnosis of preeclampsia, hypertension, or gestational diabetes (GDM) alone, so despite being etiologically distinct diseases, women were categorized as diagnosed with gestational related disease or not \[approximately 1/3 of participants; please see \[[@pone.0229567.ref018]\] and \[[@pone.0229567.ref019]\]\]. The Mann-Whitney U test was used to determine effect of categorical BMI (r \< 25 or \>25) or diagnosis of gestational related disease (yes or no for diagnosis of hypertension, preeclampsia and, or GDM during pregnancy) on *r24* of activity or rest-activity and saliva cortisol cosine fit calculated variables. Both Pearson and Spearman correlation analysis were used to evaluate the relationship between cortisol cosine analysis variables, activity cosinor variables and *r*24 with continuous BMI, gestational age at birth and blood glucose levels from glucose tolerance test. Pearson correlation was used to test the correlation between two normal variables, whereas Spearman analysis dealt with any type of data as it is not sensitive to outliers.

Results {#sec008}
=======

Demographics of the study population {#sec009}
------------------------------------

The mean age of study participants was 23 ± 3.8 years old, with 64% indicating they were Black or African American and of low socioeconomic status. Detailed descriptions of the sample of the population that completed actigraphy \[[@pone.0229567.ref018]\] and Pittsburgh Sleep Quality Index (PSQI) and Edinburgh Postnatal Depression Scale (EPDS) surveys \[[@pone.0229567.ref019]\] are available in our previous publications. The demographics of the population that completed the saliva collection arm was similar to the population that completed actigraphy and PSQI survey components of the study ([Table 1](#pone.0229567.t001){ref-type="table"}). Our aim was to have 25 women complete the saliva arm of our study. Due to quality of samples (for example small amounts) or incorrect sampling protocol (as noted in participant logs) analysis of cortisol levels was conducted on samples from 22, 20 and 20 women at gestation weeks 22, 32 and postpartum period, respectively ([Table 1](#pone.0229567.t001){ref-type="table"}).

10.1371/journal.pone.0229567.t001

###### Demographic and health characteristics of saliva cortisol study sample *(n* = 24*)*.

![](pone.0229567.t001){#pone.0229567.t001g}

  Characteristics                                                     *n* (%)
  ------------------------------------------------------------------- ---------
  Race                                                                
      African American                                                15 (63)
      White                                                           2 (8)
      More than one race, or other                                    4 (16)
      Unknown/not reported                                            3 (13)
  Ethnicity                                                           
      Hispanic                                                        5 (21)
      not Hispanic or Latino                                          19 (79)
  Education                                                           
      Graduate degree                                                 3 (13)
      Bachelor degree                                                 2 (8)
      Associate degree                                                1 (4)
      High school or GED                                              16 (67)
      No high school or GED                                           2 (8)
  Yearly household income                                             
      Less than \$10,000                                              12 (50)
      ≥\$10,000, but \<\$25,000                                       3 (13)
      ≥\$25,000, but \<\$50,000                                       7 (29)
      ≥\$50,000                                                       2 (8)
  Diagnosis                                                           
      Pre-eclampsia                                                   3 (13)
      GDM                                                             4 (16)
      Hypertension                                                    6 (25)
      Any gestational disease[^a^](#t001fn002){ref-type="table-fn"}   7 (29)
      BMI \>25                                                        13 (54)
  Participants with complete saliva samples                           
      Gestational week 22                                             22 (92)
      Gestational week 32                                             20 (83)
      Postpartum 24--48 h                                             20 (83)
      All three time points                                           15 (50)

Data presented describe the demographics and rate of diagnosis among the 26% of participants (*n* = 24) who participated in the saliva arm of the study. (The total sample size was *N* = 92).

^a^Any gestational disease is percent of population with any diagnosis of preeclampsia, hypertension and/or gestational diabetes mellitus (GDM); therefore, percent not additive across diagnosis. BMI = Body mass index.

Circadian rhythms of rest-activity during gestational weeks 22 and 32 and postpartum week one {#sec010}
---------------------------------------------------------------------------------------------

Actigraphic data plots of mean activity at 30-sec epochs across 6 days and all participants show clear circadian rhythms of rest-activity during the three study time points ([Fig 1](#pone.0229567.g001){ref-type="fig"} and [S2 Fig](#pone.0229567.s002){ref-type="supplementary-material"}). Plots of actigraphic data of an individual participant demonstrates a loss of diurnal pattern of rest-activity in the first week postpartum relative to gestational time points, which was characteristic of multiple women ([S2 Fig](#pone.0229567.s002){ref-type="supplementary-material"}). A comparison of *R*^2^ values calculated from cosine analysis of rest-activity data revealed a significant decrease in fit of the data to a 24-hr rhythm between gestational weeks 22 and 32 and then again between gestational week 32 and postpartum week one ([Table 2](#pone.0229567.t002){ref-type="table"}). The amplitude was significantly decreased between the second and third trimester recordings, and dropped again between gestational week 32 and postpartum week one. The timing of the acrophase (peak) of activity shifted to nearly an hour earlier from a mean time of 16:45 at gestational weeks 22 to 15:38 during gestational week 32, and then shifted ahead by more than hour for a mean peak in activity at 16:52 during postpartum week one ([Table 2](#pone.0229567.t002){ref-type="table"}).

![Mean activity of women every 30 sec across 6 days of recording during gestational week 22 (A) 32 (B) and postpartum week one (C). Data were averaged among all participants by time point across the first six days of recording.](pone.0229567.g001){#pone.0229567.g001}

10.1371/journal.pone.0229567.t002

###### Cosinor analysis variables of activity rhythms during gestational week 22 (G22), gestational week 32 (G32) and postpartum week 1 (PPW1).

![](pone.0229567.t002){#pone.0229567.t002g}

                   G22 *n =* 50    G32 *n =* 46    PPW1 *n =* 39   p-value of difference   
  ---------------- --------------- --------------- --------------- ----------------------- ----------
  R^2^ (sd)        0.14 (0.05)     0.13 (0.07)     0.06 (0.04)     0.35                    0.17
  Mesor (sd)       84.97 (26.99)   84.40 (23.83)   81.92 (26.35)   0.04                    \<0.0001
  Amplitude(sd)    67.58 (25.26)   62.54 (24.63)   42.53 (18.23)   0.03                    \<0.001
  Acrophase (sd)   16:45 (3.25)    15:38 (2.49)    16:52 (1.75)    0.007                   \<0.0001

During gestational week 22 and 32 and postpartum week one, mean autocorrelation coefficients of activity were 0.14, 0.13, and 0.06, respectively ([Fig 2](#pone.0229567.g002){ref-type="fig"}). The *r*24 values were lower than those reported for other populations \[[@pone.0229567.ref021], [@pone.0229567.ref022]\], and previous studies of pregnant women \[[@pone.0229567.ref002]\]. Actigraphic data were collected in 30 sec epochs for our study, whereas other studies used 1 min epochs. We tested the effect of collapsing data and increasing time intervals to 1 min, 5 min, 10 min and 30 min. As the time interval was increased, the *r*24 values increased. For example, collapsing gestational week 22 data to 1 min intervals increased *r*24 to 0.17, whereas mean *r*24 increased to 0.35 when 30 min intervals were applied. However, the difference between *r*24 during gestational weeks 22 and 32 became less significant. The mean *r*24 using 30 sec epochs for calculations was different between gestational weeks 22 and 32 (*p*\<0.05; [Fig 2](#pone.0229567.g002){ref-type="fig"}). Mean *r*24 was also significantly different between gestational week 32 and postpartum week one ([Fig 2](#pone.0229567.g002){ref-type="fig"}). The difference in *r*24 between gestational weeks 22 and 32 was lost when 1 min intervals of activity were used for calculations. However, the difference between gestational time points and postpartum week one *r*24 remained through 30 min intervals.

![The 24 h autocorrelation coefficient (*r*24) of rest-activity data during gestational week 22 (G22) and 32 (G32) and postpartum week 1 (PPW1) calculated using 30 sec epochs.\
Repeated measures ANOVA was used to determine effect of gestational or postpartum time point on *r*24, followed by Bonferoni adjustments for multiple comparisons.](pone.0229567.g002){#pone.0229567.g002}

Circadian rhythm analysis of salivary cortisol in women during gestational weeks 22 and 32 and 24--48 h postnatal {#sec011}
-----------------------------------------------------------------------------------------------------------------

Study participants were asked to collect saliva samples every 4 hr over a 24 hr period during gestational weeks 22 and 32 relative to waking to capture circadian rhythms ([Fig 3A and 3B](#pone.0229567.g003){ref-type="fig"}; [S3A Fig and S3B Fig](#pone.0229567.s003){ref-type="supplementary-material"}). Saliva circadian sample collection in the early postpartum was begun relative to the time of parturition, with all samples collected beginning at 24 hr from birth of infant ([Fig 3C](#pone.0229567.g003){ref-type="fig"} and [S3C Fig](#pone.0229567.s003){ref-type="supplementary-material"}). Cosine regression analysis found the acrophase of cortisol was reached 18.34 hr after start of postpartum sampling which was approximately 42 hr from the time of birth. To enable comparison of time of acrophase across all sampling periods, data were expressed relative to clock time ([Fig 3D](#pone.0229567.g003){ref-type="fig"}). Cosine fit regression analysis found time of acrophase was not significantly different across the study period, with it calculated as 09:07 during gestational week 22, 09:38 during gestational week 32 and 08:57 for the postnatal 24--48 hr period ([Table 3](#pone.0229567.t003){ref-type="table"}).

![Saliva cortisol concentrations across a 24 h period during gestational weeks 22 and 32, and 24--48 h postpartum.\
Box plots of saliva cortisol relative to time of waking (0 h) during gestational week 22 (A) and 32 (B); or relative to time of birth, beginning at 24 h postpartum. Horizontal line within box plot indicates median, X indicates mean, and dots are outliers. Scatter plot of saliva cortisol levels versus clock time (D), with cosine fitted curve of data collected during gestational week 22 (red), 32 (black) and post-partum 24--48 h (blue).](pone.0229567.g003){#pone.0229567.g003}

10.1371/journal.pone.0229567.t003

###### Mean of cosinor analysis variables of saliva cortisol during gestational week 22 (G22), gestational week 32 (G32) and postpartum 24--48 hr (PP24-48).

![](pone.0229567.t003){#pone.0229567.t003g}

                              G22 (n = 22)   G32 (n = 20)   PP24-48 (n = 20)   *p*-value of difference   
  --------------------------- -------------- -------------- ------------------ ------------------------- --------
  Mesor (sd) μg/dL            0.29 (0.15)    0.27 (0.15)    0.19 (0.13)        NS                        \<0.05
  Amplitude (sd) μg/dL        0.22 (0.21)    0.19 (0.11)    0.12 (0.11)        NS                        \<0.05
  Acrophase (sd) clock time   09:07 (1.08)   09:38 (1.16)   08:57 (1.63)       NS                        NS
  AUC (sd) μg/dL per 24 h     5.88 (3.90)    5.77 (3.19)    3.94 (2.84)        NS                        \<0.01

NS indicates not significant

The AUC of cortisol concentration was not different between gestational week 22 and 32, but was decreased (*p* = 0.009) between the third trimester sampling period and the first 24--48 hr post-partum ([Table 3](#pone.0229567.t003){ref-type="table"}). Similarly, mesor (or mean cortisol levels across the 24 hr sampling) was not different between gestational week 22 and 32, but dropped (*p*\<0.05) between gestational week 32 and the postpartum sampling periods ([Table 3](#pone.0229567.t003){ref-type="table"}). The amplitude of cortisol level also dropped (*p* \<0.05) from gestational week 32 to postpartum 24--48 hr, but was not significantly different between gestational week 22 and 32 ([Table 3](#pone.0229567.t003){ref-type="table"}).

Analysis of the relationship among activity and cortisol rhythms during gestational weeks 22 and 32 and in the postpartum with health outcomes {#sec012}
----------------------------------------------------------------------------------------------------------------------------------------------

The relationship of fit of activity rhythms to a 24 hr period (*R*^2^), autocorrelation coefficient (*r*24), mesor, amplitude, and acrophase with maternal health indicators was analyzed by comparing variables between groups of women with prepregnancy BMI greater or less than 25, or without and with diagnosis of gestational related disease at each study time point. Women with prepregnancy BMI greater than 25 were found to have lower (*p* = 0.01) mesor of activity during gestational week 32 ([Fig 4A](#pone.0229567.g004){ref-type="fig"}) and lower (*p* = 0.03) *r*24 during postpartum week one than women with BMI less than 25 (*r*24 = 0.07 ± 0.03 and *r*24 = 0.04 ± 0.04 for BMI \<25 and \>25, respectively). During gestational week 32, women diagnosed with gestational related disease (hypertension, gestational diabetes mellitus and/or preeclampsia) had lower (*p* = 0.014) amplitudes of activity ([Fig 4B](#pone.0229567.g004){ref-type="fig"}) and poorer (*p* = 0.021) cosinor curve fitting compared to participants without disease (*R*^2^ = 0.15 ± 0.06 versus *R*^2^ = 0.10 ± 0.06 for without and with disease, respectively). There was also evidence for a potential relationship (*p* = 0.08) of women with gestational related disease having lower *r*24 during gestational week 32.

![Relationship of rest-activity circadian rhythm variables to maternal-fetal health indicators.\
Mesor of activity during gestational week 32 was different between women with prepregnancy BMI \<25 (blue) and \>25 (orange) at *p* = 0.01 (A). Amplitude of activity during gestational week 32 was different between women without (orange) and with (blue) diagnosis of gestational related at *p* = 0.014 (B). Horizontal line within box plot indicates median, X indicates mean, and dots are outliers. Spearman correlation analysis of the relationship between gestational age of infant at birth and *r*24 during gestational week 32, *r* = 0.44; *p* = 0.03 (C), and the relationship between prepregnancy BMI (continuous variable) to *r*24 during gestational week 32, *r* = -0.25; *p =* 0.06 (D).](pone.0229567.g004){#pone.0229567.g004}

There was a positive relationship between gestational age of infant at birth and *r*24 (*r* = 0.44; *p* = 0.03; [Fig 4C](#pone.0229567.g004){ref-type="fig"}), *R*^2^ (*r* = 0.37; *p* = 0.01) and mesor (*r* = 0.38; *p* = 0.01) of activity during gestational week 32 ([Table 4](#pone.0229567.t004){ref-type="table"}). There was also evidence for a potential relationship between *r*24 at gestational week 22 and gestational age of infant at birth (*r* = 0.28; *p* = 0.06). Prepregnancy BMI (continuous variable) was negatively related to *r*24 (*r* = -0.25; *p =* 0.06; [Fig 4D](#pone.0229567.g004){ref-type="fig"}) and mesor (-0.27; p = 0.07) of activity during gestational week 32 ([Table 4](#pone.0229567.t004){ref-type="table"}). There was no relationship between activity variables and blood glucose levels.

10.1371/journal.pone.0229567.t004

###### Regression analysis of relationship between maternal-fetal health indicators and actigraphic sleep variables with rest-activity and cortisol rhythm variables by study time point.

![](pone.0229567.t004){#pone.0229567.t004g}

  Variable                             Variable             Time point   *r*     *p*-value
  ------------------------------------ -------------------- ------------ ------- -----------
  Gestational age of infant at birth   Activity *r*24       G22          0.28    0.06
  Activity *r*24                       G32                  0.44         0.03    
  Activity *R*^2^                      G32                  0.37         0.01    
  Activity mesor                       G32                  0.38         0.01    
  Cortisol mesor                       PP 24--48            0.47         0.03    
  Cortisol AUC                         PP 24--48            0.5          0.02    
  BMI                                  Activity *r*24       G32          -0.24   0.06
  Activity mesor                       G32                  -0.27        0.07    
  Cortisol mesor                       PP 24--48            -0.47        0.03    
  Cortisol AUC                         PP 24--48            -0.39        0.09    
  Blood glucose                        Cortisol acrophase   G22          0.58    0.006
  Cortisol acrophase                   G32                  0.48         0.07    
  WASO                                 Cortisol mesor       G22          0.58    0.03
  Cortisol AUC                         G22                  0.69         0.002   
  Sleep efficiency                     Cortisol AUC         G22          -0.52   0.03
  Activity acrophase                   Cortisol acrophase   All          0.66    0.001

Women diagnosed with a gestational related disease had significantly (*p* = 0.015) lower mesor of cortisol saliva concentration \[0.09 (0.05) μg/dL; mesor (s.d.)\] during the postpartum sampling period than those without gestational-related disease \[0.22 (0.14) μg/dL\]. Similarly, AUC was different (*p*\<0.05) between these groups; women diagnosed with gestational related disease \[1.8 (1.1) μg/dL per 24 hr\] had significantly lower AUC cortisol levels during postpartum sampling period than those who were not \[4.65 (2.9) μg/dL per 24 hr\]. Interestingly, AUC values for cortisol at gestational week 32 showed the opposite trend, with women diagnosed with gestational related disease \[0.30 (0.05) μg/dL per 24 hr\] tending (*p* = 0.09) to have higher cortisol levels than those without disease \[0.27 (0.17) μg/dL per 24 hr\].

Spearman correlation analysis was used to determine if circadian cortisol variables were related to prepregnancy BMI (continuous), blood glucose level and gestational age at birth. The time of saliva cortisol acrophase was positively related to blood glucose levels during gestational week 22 ([Fig 5A](#pone.0229567.g005){ref-type="fig"}); this relationship was somewhat lost by gestational week 32 ([Table 4](#pone.0229567.t004){ref-type="table"}). Postpartum cortisol mesor ([Fig 5B](#pone.0229567.g005){ref-type="fig"}) and AUC were negatively related with BMI ([Table 4](#pone.0229567.t004){ref-type="table"}). Mesor and AUC ([Fig 5C](#pone.0229567.g005){ref-type="fig"}) during the postpartum sampling period were positively related to gestational age at birth.

![Relationship of saliva cortisol circadian rhythm variables to maternal-fetal health inidicators.\
Relationship between blood glucose levels with time of cortisol acrophase during gestational week 22, *r* = 0.58, *p* = 0.006 (A); Relationship between prepregnancy BMI and cortisol mesor during the 24--48 h period postpartum, *r* = -0.47, *p* = 0.03 (B); Relationship between gestational age at birth and cortisol AUC during postpartum 24--48 h period, *r* = 0.50, *p* = 0.02.](pone.0229567.g005){#pone.0229567.g005}

Correlation analysis of activity rhythm variables with cortisol variables found the timing of cortisol acrophase was significantly related to the timing of peak activity (*r* = 0.66; *p* = 0.001) during gestational week 22. Moreover, during gestational week 22, minutes of wake after sleep onset (WASO) was positively related to cortisol mesor and AUC, whereas sleep efficiency was negatively related to cortisol AUC during gestational week 22 ([Table 4](#pone.0229567.t004){ref-type="table"}). In the final analysis, data from all three time points were combined to determine the relationship of *r*24, cortisol, self-reported sleep quality (PSQI) and maternal mood (EPDS) scores. This analysis revealed that *r*24 of activity was significantly related with cortisol amplitude (*r* = 0.33; *p* = 0.01) and negatively related to PSQI score (*r* = -0.17; *p* = 0.05). There was no relationship to mood scores.

Discussion {#sec013}
==========

Analysis of 24 hr rest-activity and saliva cortisol rhythms across the second and third trimester of gestation and in the early postpartum period showed that rhythms changed as women transitioned through these unique metabolic-physiological states. In general, circadian rhythms of activity progressively diminished across gestation and into the postpartum. More robust activity rhythms associated with more robust cortisol rhythms. Moreover, potential relationships among rest-activity, sleep and cortisol rhythms with maternal-fetal health indicators were revealed. The final model across all study time points indicated 11% of cortisol amplitude was explained by the quality of circadian rest-activity rhythm, as indicated by the autocorrelation coefficient (*r*24), and 3% of the cortisol amplitude was explained by the subjective sleep (PSQI) score. Autocorrelation coefficient was also positively associated with gestational age of infant at birth, suggesting that more irregular sleep-activity rhythms may be associated with earlier term births. To our knowledge, this pilot study is one of the first investigations reporting on objectively measured rest-activity rhythms and the longitudinal relationship to salivary cortisol rhythms and pregnancy disorders.

Circadian rhythms become attenuated as pregnancy progresses and with the onset of the early postpartum period {#sec014}
-------------------------------------------------------------------------------------------------------------

Physiologic-metabolic adaptations occur as females transition through reproductive states, with maternal circadian rhythms of behavior and physiology changing throughout pregnancy and lactation \[[@pone.0229567.ref023]--[@pone.0229567.ref030]\]. Previous studies reported overall activity levels of pregnant women were decreased and onset of activity shifted to an earlier time relative to non-pregnant states \[[@pone.0229567.ref031]\]. We found no difference in time of waking or start of sleep time between gestational weeks 22 and 32 in this population of women \[[@pone.0229567.ref018]\], but there was a shift in time of peak of activity to nearly an hour earlier in the third trimester relative to second trimester. Mean activity (mesor) of women in our population also decreased as pregnancy progressed from gestational weeks 22 to 32. There was a further decline in activity in the early postpartum period, and time of peak activity shifted back to the later time recorded for gestational week 22. The quality of rest-activity rhythms, as indicated by *r*24, decreased between gestational weeks 22 and 32 and then again between the third trimester and the first week postpartum, which is consistent with findings of others \[[@pone.0229567.ref032]\].

We found that cortisol mesor, AUC and amplitude were not different between the gestational time points, however, mesor, AUC and amplitude significantly decreased between the third trimester and 24--48 h postpartum. Comparison of cortisol concentrations measured in our study with those previously reported, found highly similar saliva concentrations during gestational week 32 and the postpartum sampling period \[[@pone.0229567.ref033]\]. The magnitude of drop of cortisol levels from gestational week 32 to the early postpartum was also similar between our studies \[[@pone.0229567.ref033]\]. However, levels of salivary cortisol were higher during gestational week 22 in our study than those reported previously by this same group \[[@pone.0229567.ref033]\].

During gestational week 22 the timing of cortisol acrophase was significantly related to the timing of peak activity. However, the significant association was lost by the third trimester. We speculate that this may be because circadian rhythms are masked by other dominant physiological changes in women that are underway in the third trimester. Alternatively, a general dampening in circadian rhythms associated with later stages of gestation may have caused loss of association and reflect maternal physiological adaptations needed to support this reproductive state. In particular, circadian rhythms of rest-activity dampened in women between gestational week 22 and 32. Although cortisol mesor and amplitude were not different between gestational time points in our study, it is generally accepted that rhythms of cortisol become attenuated as pregnancy progresses. Attenuation of circadian rhythms of behavior and physiology have also been reported for patterns of food intake in pregnant and lactating rodents \[[@pone.0229567.ref030]\], and circadian rhythms of gene expression \[[@pone.0229567.ref034]\]. More studies are needed to understand the interaction between circadian-metabolic systems in pregnant and lactating females to understand the significance of changes.

Less robust activity rhythms and elevated cortisol levels are associated with poorer maternal-fetal health indicators {#sec015}
---------------------------------------------------------------------------------------------------------------------

Despite the general dampening of circadian rhythms as pregnancy progresses, analysis of the association of rest-activity circadian rhythm parameters with health indicators, support the importance of maintaining circadian rhythms for maternal-fetal health. In particular, more regular rest-activity rhythms during gestational week 32, as reflected in higher *r*24, were associated with greater gestational age of infant at birth. Moreover, women diagnosed with gestational related disease or BMI greater than 25 had lower amplitudes of activity and poorer fitting of rest-activity patterns to 24 hr rhythms. Circadian and metabolic systems are intimately linked and disruption of circadian rhythms is often associated with development of metabolic syndrome, obesity, and diabetes \[[@pone.0229567.ref035]--[@pone.0229567.ref038]\], and the association of higher BMI with poorer rest-activity rhythms is consistent with findings of studies of nonpregnant women \[[@pone.0229567.ref039], [@pone.0229567.ref040]\].

Activity of the hypothalamic-pituitary-adrenal (HPA) axis is dysregulated in obese individuals \[[@pone.0229567.ref041]\]. Dysregulation of the HPA axis in non-pregnant obese women is evident in attenuation of the cortisol circadian rhythm, higher basal levels and alterations in stress response \[[@pone.0229567.ref041]\]. Studies of others found that during the third trimester, women with prepregnancy obesity had elevated evening cortisol versus normal weight women \[[@pone.0229567.ref042]\]. We did not find this in our study, but interestingly found that in the 24--48 h period immediately postpartum there was a negative relationship between cortisol mesor and amplitude with prepregnancy body mass index. In the third trimester, women diagnosed with gestational-related disease showed a trend for higher cortisol levels, but in the postpartum 24--48 hr period cortisol levels were significantly lower in women with disease than women without. The trend for higher cortisol levels prepartum in women diagnosed with gestational disease is consistent with the relationship of hypercortisolism with gestational diabetes \[[@pone.0229567.ref043], [@pone.0229567.ref044]\], as well as gestational hypertension and preeclampsia \[[@pone.0229567.ref045]\]. We speculate that the significantly lower levels of free cortisol in the postpartum period in women with higher BMI or diagnosis of gestational related disease reflects a potential refractory period in the HPA axis related to these pathological states. We plan to investigate this further in a larger study population.

The time of cortisol acrophase was positively related to blood glucose levels during gestational week 22. Thus, when cortisol level peaked later in the day, it tended to associate with elevated blood glucose (hyperglycemia). Cortisol regulates blood glucose, with cortisol increasing circulating blood glucose, and consistent with this, is the similar phases of circadian rhythms of cortisol and glucose \[[@pone.0229567.ref046]\]. Glucose tolerance and clearance also vary by time of day in pregnant women \[[@pone.0229567.ref047], [@pone.0229567.ref048]\]. The association between later cortisol acrophase and higher blood glucose maybe indicative of dysregulation of the HPA axis in individuals with hyperglycemia \[[@pone.0229567.ref044]\]. Moreover, during the second trimester the minutes of wake after sleep onset (WASO) was positively related to cortisol levels, whereas sleep efficiency was negatively related to cortisol levels. These relationships suggest that poorer sleep is associated with higher cortisol levels during pregnancy. Meta-analysis found a negative association between maternal saliva cortisol and infant birth weight \[[@pone.0229567.ref049]\]. Women with Cushing\'s disease or Cushing\'s syndrome, which is characterized by hypercortisolism, during pregnancy have an increased risk for small-for-gestational-age babies and adverse pregnancy outcomes \[[@pone.0229567.ref050], [@pone.0229567.ref051]\]. Studies of sheep found that increasing maternal cortisol concentrations slowed fetal growth rate and was associated with alterations in glucose homeostasis \[[@pone.0229567.ref052]\]. Together findings support a potential for a mechanistic link between sleep disruption and elevated cortisol, which alters glucose homeostasis and has associated negative effects on maternal-offspring health and thus warrant further investigation.

Considerations of study population and study limitations {#sec016}
--------------------------------------------------------

Women recruited for the study were primarily of lower socioeconomic status. Pregnant women of lower socioeconomic status were found to have lower cortisol awakening responses and less of a change in cortisol levels across a day \[[@pone.0229567.ref053]\], indicating a general dampening of cortisol rhythms and responses in this population. Across all study time points *r*24 was significantly related with cortisol amplitude, which suggests that rest-activity behaviors affect the quality of cortisol rhythms. Our previous study of this population, found that women who worked daytime shifts had significantly better self-assessed sleep quality than those who worked evening-night or rotating shifts \[[@pone.0229567.ref019]\]. The subset of the population that was unemployed had a wide variability in sleep quality scores, resulting in no difference in sleep quality between group and day-time or shift/night workers. In this study, we found that across all time points the more-robust activity rhythms were associated with better self-assessed sleep scores (PSQI score). Together, these findings support the need for development of studies designed to test if interventions that target maintaining regular daily activity behaviors during pregnancy regulate circadian rhythms of physiology to better insure maternal-fetal health, particularly among women of lower socioeconomic status.

The small sample size of this pilot study limited the ability to establish strong relationships between rest-activity rhythms and maternal-fetal health. Establishing a relationship between cortisol circadian variables and maternal-fetal health was even more limited by sample size. Moreover, the study relied on participants self-reporting time of saliva sampling instead of using track-cap devices, which electronically record the time of sampling. Studies have found that nonadherence to saliva sampling in ambulatory settings can significantly affect cortisol variables \[[@pone.0229567.ref054]\]. Additionally, saliva cortisol concentration was measured using ELISA. Although, studies found that immunoassay analysis of saliva cortisol concentration largely comparable to liquid chromatography tandem mass spectrometry (LC-MS/MS), immunoassay values were consistently greater than LC-MS/MS and the limit of detection was 5 nmol/L (0.18 μg/dL) or more \[[@pone.0229567.ref055]\]. Despite limitations, these data support the need for further investigations into the interactions among circadian rhythms of cortisol with rest-activity rhythms, sleep metrics and maternal-fetal health.

Conclusion {#sec017}
==========

Rest-activity rhythms were related to cortisol rhythms in pregnant women, with amplitude of cortisol related to rest-activity circadian rhythm quality. Variables reflecting relative quality of rest-activity circadian rhythms during pregnancy were related to gestational age of infant at birth, and thus may reflect maternal-fetal health. Study findings also support a relationship between cortisol levels, blood glucose, and rest-activity rhythms, and thus call for further investigations to determine if circadian system and sleep disruption affect the metabolic-hormonal systems in a manner that potentially impacts maternal-fetal health.

Supporting information {#sec018}
======================

###### Study design.

(DOCX)

###### 

Click here for additional data file.

###### 

Actigraphs of a representative single study participant across study time points and cosine fitted curve (red) during gestational week 22 (A), 32 (B) and postpartum week one (C). Every 30-sec epoch of activity each day was averaged across all recorded days within a subject, and then these data were averaged across subjects to express data within a 24 h period and cosine fitted curve (red) was calculated for gestational week 22 (D), 32 (E) and postpartum week one (F).

(DOCX)

###### 

Click here for additional data file.

###### 

Spaghetti graphs of saliva cortisol concentration of each study participant during gestational week 22 (A), 32 (B) and postpartum week one (C). Cortisol level units are μg/dL.

(DOCX)
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Click here for additional data file.
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Reviewer \#1: PONE-D-29597

The HPA-axis is influenced by a wide variety of factors in health and disease. The present manuscript has the title "Longitudinal relationship between rest-activity and cortisol circadian rhythms during pregnancy with maternal-health: A pilot study.

1\. The title, like the manuscript itself, struggles with stating unequivocally what the focused aim and results of the study are. The question is whether it the relationship between rest-activity and cortisol circadian rhythms in pregnancy or cortisol and maternal health or both?

2\. A shorter and more pointed title, e.g. "The effects of maternal health and rest-activity on salivary cortisol concentrations in pregnancy" gives a clearer picture.

3\. The rest-activity registration and advanced analysis of the cortisol diurnal variation play a crucial role when describing the results of the study, but the introduction and discussion parts of the manuscript contain voluminous references to cortisol concentrations in other contexts. The authors are advised to shorten the manuscript by at least a third by removing text that only marginally supports the aim and results of the study.

4\. The authors refer to the two following publications for further information about the sample of pregnant women from the population: Ahmed AH, Hui S, Crodian J, Plaut K, Haas D, Zhang LS, et al. Relationship Between Sleep Quality, Depression Symptoms, and Blood Glucose in Pregnant Women. Western J Nurs Res. 2019;41(9):1222-40. And Casey T, Sun H, Burgess HJ, Crodian J, Dowden S, Cummings S, et al. Delayed Lactogenesis II is Associated With Lower Sleep Efficiency and Greater Variation in Nightly Sleep Duration in the Third Trimester. J Hum Lact. 2019;35(4):713-24. In the opinion of the present reviewer it is absolutely crucial to include the combined comprehensive information provided in the two manuscripts in the description of the population and the sample from the population used in the study. The concept "convenience sample" should be used to use an established term to describe the sampling. It is also crucial to describe the dropout rate and discuss the risks of confounding caused by the selection procedure and the dropout.

5\. The research design used has possibly been frowned on by earlier reviewers and editors. My take on the matter is different. In order to study the functions of the HPA-axis in humans, it may be a substantial advantage to study the HPA axis under stress as in the present study. Substantial stress is obviously more likely to be found in a group of women from a disadvantageous population of pregnant women. My suggestion is therefore that the authors see the group of pregnant women they have studied primarily as an advantage rather than a problem due to dropouts etc. They may therefore even consider stating this flat out in the title, e.g. "The effects of maternal health and rest-activity on salivary cortisol concentrations in pregnancy in women from a disadvantaged population" and clearly point out the advantages of their study design which also evidently results in the dropouts etc. inevitably occurring.

6\. The description of the demographics of the study population on page 11 lines 201-211 should be given in the Material and Methods section of the manuscript as part of the research design and not in the results section of the manuscript as unexpected challenges in the results of the study.

7\. The authors are encouraged to make clearer in the manuscript which effect they consider the rest-activity of the subjects have on the cortisol circadian rhythmicity.

8\. The two last lines on page 18 report the Pearson r correlation coefficient. R=0.33 means that 0.33\^2=0.1089 meaning that 11% of the cortisol amplitude is explained by the r24 and that 0.17\^2=0.0289 meaning that 3% of the cortisol amplitude is explained by the PSQI score. In the eyes of the present reviewer this type of information is even more informative than the r values and probability statements themselves.

9\. The last sentence of the abstract (page 2, lines 38-40) should be deleted since it only states the obvious.

10\. Page 3, line 64 reads "pregnancy total plasma cortisol". The concept "total plasma cortisol rises progressively" is only logical if "total concentration of cortisol rises progressively" is meant. Since the authors measure the concentrations of cortisol in saliva as reflection of the free fraction of cortisol in plasma the concept concentration seems reasonable.

11\. Page 4, line 67-68 states "which is the biologically active component in serum". The authors will agree that serum is a component of blood which only exists if whole blood is allowed to coagulate fully and is subsequently centrifuged. Serum never exists in vivo in a patient. Line 68 should therefore read "component in plasma (14)".

12\. Page 8, line 147 should read "All samples were run in duplicate and the mean value of the duplicate results used."

13\. The authors should detail the method(s) and probability criteria used for outlier analysis

Reviewer \#2: Casey et al investigate the relationship between rest activity rhythms and salivary cortisol rhythms and how they are related to maternal fetal health indicators. Various relationships are found between variables. The paper is written well but various issues need addressing.

1\. It is not clear what the primary objective of the study was and various findings are presented with no focus on the most important. What is the primary aim of the study? What is the main question?

2\. It would have been useful to have a control group of individuals that are not pregnant to assess how different from normal physiology the changes we are observing are. Maybe comparison to model data in the literature could be useful.

3\. Health status was one of the reasons for a large number of withdrawals. Could important data have been lost and could this have influenced the final outcomes as a number of health status variables were being assessed?

4\. Are the postpartum changes for rest activity and cortisol clinically significant? Is the difference to gestational levels relevant and why. this must be discussed

5\. Saliva cortisol is measured by immunoassay not LC-MS/MS. This is a limiting factor of the study and should be discussed.

6\. The units for AUC should have a time component.

7\. How does one explain the lower cortisol mesor postpartum in those with gestational disease than those without gestational disease?

8.Figure 3 could be improved by showing a spaghetti chart for all individual cortisol rhythms. Figure 3D does not give that much useful information and one could draw the three mean cosinors for each time point

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]
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Responses to Editor's and Reviewers' Comments

Editor.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming.

done

2\. Specifically, please add information on whether consent for using newborn data was sought from the parents. In the ethics statement in the Methods and online submission information, please ensure that you have specified (i) whether consent was suitably informed and (ii) what type you obtained (for instance, written or verbal).

Information was added.

3\. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

Title was edited in both online submission and title page of manuscript.

Both reviewers commented that data needed to be made freely accessible, and so were deposited here: <https://purr.purdue.edu/publications/3376>

Reviewer \#1: PONE-D-29597

The HPA-axis is influenced by a wide variety of factors in health and disease. The present manuscript has the title "Longitudinal relationship between rest-activity and cortisol circadian rhythms during pregnancy with maternal-health: A pilot study.

1\. The title, like the manuscript itself, struggles with stating unequivocally what the focused aim and results of the study are. The question is whether it the relationship between rest-activity and cortisol circadian rhythms in pregnancy or cortisol and maternal health or both?

RE: In order to better frame, and justify the pilot study we rewrote the opening of the introduction and stream-lined the content. The objectives of the study were also rewritten, and hypothesis statement added.

The abstract was also edited to better highlight importance of study and relevant findings.

2\. A shorter and more pointed title, e.g. "The effects of maternal health and rest-activity on salivary cortisol concentrations in pregnancy" gives a clearer picture.

The title was changed to make more pointed.

3\. The rest-activity registration and advanced analysis of the cortisol diurnal variation play a crucial role when describing the results of the study, but the introduction and discussion parts of the manuscript contain voluminous references to cortisol concentrations in other contexts. The authors are advised to shorten the manuscript by at least a third by removing text that only marginally supports the aim and results of the study.

Introduction was rewritten and streamlined to only pertinent information as recommended.

4\. The authors refer to the two following publications for further information about the sample of pregnant women from the population: Ahmed AH, Hui S, Crodian J, Plaut K, Haas D, Zhang LS, et al. Relationship Between Sleep Quality, Depression Symptoms, and Blood Glucose in Pregnant Women. Western J Nurs Res. 2019;41(9):1222-40. And Casey T, Sun H, Burgess HJ, Crodian J, Dowden S, Cummings S, et al. Delayed Lactogenesis II is Associated With Lower Sleep Efficiency and Greater Variation in Nightly Sleep Duration in the Third Trimester. J Hum Lact. 2019;35(4):713-24. In the opinion of the present reviewer it is absolutely crucial to include the combined comprehensive information provided in the two manuscripts in the description of the population and the sample from the population used in the study. The concept "convenience sample" should be used to use an established term to describe the sampling. It is also crucial to describe the dropout rate and discuss the risks of confounding caused by the selection procedure and the dropout.

The total enrollment under population was added to the methods section as well as other details. 'Convenience sample' was added.

5\. The research design used has possibly been frowned on by earlier reviewers and editors. My take on the matter is different. In order to study the functions of the HPA-axis in humans, it may be a substantial advantage to study the HPA axis under stress as in the present study. Substantial stress is obviously more likely to be found in a group of women from a disadvantageous population of pregnant women. My suggestion is therefore that the authors see the group of pregnant women they have studied primarily as an advantage rather than a problem due to dropouts etc. They may therefore even consider stating this flat out in the title, e.g. "The effects of maternal health and rest-activity on salivary cortisol concentrations in pregnancy in women from a disadvantaged population" and clearly point out the advantages of their study design which also evidently results in the dropouts etc. inevitably occurring.

Thank you for this comment. We added the phrase 'from a disadvantage population'. Because of the pilot nature and design of the study we limited title to claims of 'relationships'.

6\. The description of the demographics of the study population on page 11 lines 201-211 should be given in the Material and Methods section of the manuscript as part of the research design and not in the results section of the manuscript as unexpected challenges in the results of the study.

Recruitment information was moved to the Methods section.

7\. The authors are encouraged to make clearer in the manuscript which effect they consider the rest-activity of the subjects have on the cortisol circadian rhythmicity.

We removed descriptive changes in rest-activity and cortisol rhythms from abstract, to help highlight the significant relationships between these rhythms, and maternal-fetal health.

8\. The two last lines on page 18 report the Pearson r correlation coefficient. R=0.33 means that 0.33\^2=0.1089 meaning that 11% of the cortisol amplitude is explained by the r24 and that 0.17\^2=0.0289 meaning that 3% of the cortisol amplitude is explained by the PSQI score. In the eyes of the present reviewer this type of information is even more informative than the r values and probability statements themselves.

These findings were highlighted in the opening of the discussion and conclusion.

9\. The last sentence of the abstract (page 2, lines 38-40) should be deleted since it only states the obvious.

Deleted.

10\. Page 3, line 64 reads "pregnancy total plasma cortisol". The concept "total plasma cortisol rises progressively" is only logical if "total concentration of cortisol rises progressively" is meant. Since the authors measure the concentrations of cortisol in saliva as reflection of the free fraction of cortisol in plasma the concept concentration seems reasonable.

Changed as suggested.

11\. Page 4, line 67-68 states "which is the biologically active component in serum". The authors will agree that serum is a component of blood which only exists if whole blood is allowed to coagulate fully and is subsequently centrifuged. Serum never exists in vivo in a patient. Line 68 should therefore read "component in plasma (14)".

Fixed.

12\. Page 8, line 147 should read "All samples were run in duplicate and the mean value of the duplicate results used."

Fixed.

13\. The authors should detail the method(s) and probability criteria used for outlier analysis

No outlier analysis was implemented in our statistical analysis because the sample size was so small. In the boxplots, the potential outlier (with star) is calculated by 5-number summary method where any value \> Q3 + 1.5(Q3-Q1) or \< Q1- 1.5(Q3-Q1) is considered a potential outlier (Q1 and Q3 here and 1st and 3rd quartile respectively). Due to the highly skewed data with potential outliers, we use rank based methods (like Spearman analysis) without assuming normality for the data.

Reviewer \#2: Casey et al investigate the relationship between rest activity rhythms and salivary cortisol rhythms and how they are related to maternal fetal health indicators. Various relationships are found between variables. The paper is written well but various issues need addressing.

1\. It is not clear what the primary objective of the study was and various findings are presented with no focus on the most important. What is the primary aim of the study? What is the main question?

Reviewer \#1 had similar comments, we addressed these weaknesses by rewriting the first lines of abstract and first and last paragraphs of introduction. We also streamlined content of Introduction and Discussion.

2\. It would have been useful to have a control group of individuals that are not pregnant to assess how different from normal physiology the changes we are observing are. Maybe comparison to model data in the literature could be useful.

Previous studies were conducted by others to determine differences in activity and cortisol rhythms between pregnant and non-pregnant women. This work is referred to in our manuscript. We also refer to data that measure and assessed rest-activity and relation to hormonal rhythms in non-pregnant states. Our aim was to determine if there is a relationship between rest-activity and cortisol rhythms during gestation and between these rhythms and maternal-fetal health indicators.

3\. Health status was one of the reasons for a large number of withdrawals. Could important data have been lost and could this have influenced the final outcomes as a number of health status variables were being assessed?

We apologize for mis-stating in original. Reasons for half withdrawals were: loss of fetus, moving out of area or other life events were reasons for half of study withdrawals

4\. Are the postpartum changes for rest activity and cortisol clinically significant? Is the difference to gestational levels relevant and why. this must be discussed

Very few studies have been conducted to measure these variables, and thus the need for the type of study we conducted. At this time, we do not know if there is any clinical significance. We feel that we are limited in reporting or discussing anything beyond what we did because of the limited sample size. Thus, it remains an observation that in this sample of women, levels of cortisol were significantly lower in women with BMI \>25 and who were diagnosed with gestationally-related disease. Additionally, we add that this may potentially be indicative of a refractory period in functioning of HPA, and that further research is needed.

5\. Saliva cortisol is measured by immunoassay not LC-MS/MS. This is a limiting factor of the study and should be discussed.

Added to limitations

6\. The units for AUC should have a time component.

Added throughout, per 24 hr

7\. How does one explain the lower cortisol mesor postpartum in those with gestational disease than those without gestational disease?

At this time we have no explanation, it is just an observation, that we speculate may be indicative of a refractory period in the HPA axis in this population.

8.Figure 3 could be improved by showing a spaghetti chart for all individual cortisol rhythms. Figure 3D does not give that much useful information and one could draw the three mean cosinors for each time point

Spaghetti charts were added as a supplemental figure. The lines in figure 3D, represent the cosinor curve calculated across individuals from data collected at each time period, and used to generate mean mesor, amplitude and AUC that is reported. We decided to keep, as it can be a reference/visualization tool for the reader.
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